Dec 17, 2014
In 1999, the Food and Drug Administration approved the use of Actos (pioglitazone) for the treatment of Type II Diabetes. Actos is in a class of drugs known as thiazolidinediones. These drugs can increase the body's sensitivity to insulin and help control blood sugar levels. Actos was initially thought to be safer than other drugs in this class such as Avandia, which causes an increased risk of cardiovascular events and Rezulin, which was taken off the market due to an increased risk of drug-induced hepatitis.